Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02424838 · ClinicalTrials.gov registry record · NA
22 G - 25 G SINS Trial for Pancreatic Masses
A NA study, sponsored by AdventHealth.
- Completed
- Registry status
- NA
- Development phase
- 352
- Enrollment target
NCT02424838 is a NA study that has completed, run by AdventHealth. The registered enrollment target is 352 participants.
The verdict
NCT02424838, a NA study, has completed, sponsored by AdventHealth.
- COMPLETED
- Registry status
- NA
- Development phase
- 352 participants
- Enrollment target
Study Summary
After patients have been screened and have signed informed consent, they will be taken to the endoscopy suite. Once the decision has been made to proceed with Fine Needle Aspiration (FNA), the subject will be randomized to 1 of 4 groups: * 22 gauge (G) needle with suction * 25 G needle with suction * 22 G needle without suction * 25 G needle without suction Follow-up Phone Call Phase: Unit staff will call patients 1 week after the procedure to check if patients had any adverse events from the procedure and this will be recorded onto the dataset.
Interventions
- PROCEDURE EUS-FNA of pancreatic masses
- DEVICE 22 gauge needle
- DEVICE 25 gauge needle
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 352 participants |
| Start Date | 2014-07-28 |
| Est. Completion | 2018-09-30 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02424838
The ClinicalTrials.gov registry entry for NCT02424838 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 352 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is AdventHealth, which has 95 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 3 interventions - of which EUS-FNA of pancreatic masses is the first listed.
NCT02424838 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02424838 about?
NCT02424838 is a clinical study titled "22 G - 25 G SINS Trial for Pancreatic Masses". After patients have been screened and have signed informed consent, they will be taken to the endoscopy suite. Once the decision has been made to proceed with Fine Needle Aspiration (FNA), the subject will be randomized to 1 of 4 groups: * 22 gauge (G) needle with suction * 25 G needle with suction...
What is the current status of trial NCT02424838?
This trial is currently completed. It is a NA study. The enrollment target is 352 participants. The study started on 2014-07-28. Estimated completion is 2018-09-30.
What interventions are being tested in trial NCT02424838?
The interventions under investigation include: EUS-FNA of pancreatic masses (PROCEDURE), 22 gauge needle (DEVICE), 25 gauge needle (DEVICE).
Who is sponsoring clinical trial NCT02424838?
This trial is sponsored by AdventHealth, which has 95 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.